|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01099 SINOPHARM
Nominal 
19.790 +0.110 (+0.559%) Ranking Overview
Ranking based on 5 research report(s)
Average Ranking 2.40
|
Strong Buy (1)
0
|
Buy (2)
3
|
Hold (3)
2
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 229.00 RMB (cts) | |
| Net Profit | 7,155.09 RMB (MIL) | DPS | 69.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 7,750.00 | 248.40 | 74.50 | -- | 8,332.00 | 7,430.70 |
| 2027 | 8,462.00 | 271.20 | 81.30 | -- | 8,759.00 | 7,603.70 |
| 2028 | 8,589.00 | 275.00 | 83.00 | -- | 9,245.00 | 7,819.60 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 7,545.00 | 242.00 | 73.00 | UBS | Buy | 25.70 | 23/03/2026 | |
| 2026 | 7,750.00 | 248.40 | 74.50 | CITIGROUP | Buy | 22.80 | 23/03/2026 | |
| 2026 | 8,332.00 | 267.00 | 80.40 | DAIWA | OutPerform | 21.00 | 27/10/2025 | |
| 2026 | 7,430.70 | 238.00 | 71.00 | GOLDMAN SACHS | Neutral | 19.83 | 23/03/2026 | |
| 2026 | 7,941.00 | 254.00 | 76.00 | HSBC | Hold | 19.50 | 10/11/2025 | |
| 2027 | 7,964.00 | 255.00 | 77.00 | UBS | -- | -- | 23/03/2026 | |
| 2027 | 8,462.00 | 271.20 | 81.30 | CITIGROUP | -- | -- | 23/03/2026 | |
| 2027 | 8,759.00 | 280.70 | 84.50 | DAIWA | -- | -- | 27/10/2025 | |
| 2027 | 7,603.70 | 244.00 | 73.00 | GOLDMAN SACHS | -- | -- | 23/03/2026 | |
| 2027 | 8,539.00 | 274.00 | 82.00 | HSBC | -- | -- | 10/11/2025 | |
| 2028 | 8,589.00 | 275.00 | 83.00 | UBS | -- | -- | 23/03/2026 | |
| 2028 | 9,245.00 | 296.30 | 88.80 | CITIGROUP | -- | -- | 23/03/2026 | |
| 2028 | 7,819.60 | 251.00 | 75.00 | GOLDMAN SACHS | -- | -- | 23/03/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 25/03/2026 14:10 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 7,155,094 |
| %Change | 1.495% |
| EPS / (LPS) | RMB 2.290 |
| NBV Per Share (¥) | RMB 26.902 |